Urinary stone disease. Part IV. Recurrence prevention for urinary stone disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The place and indications for recurrence prevention of urinary stone disease, general principles of recurrence prevention, role of mineral water and changes of dietary habits during recurrence prevention are reviewed in the articIe.

Full Text

Restricted Access

About the authors

V. S Saenko

FGAOU VO of I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University)

Email: saenko_vs@maiI.ru
MD, professor, Institute of Urology and Male Reproductive Health named

M. A Gazimiev

FGAOU VO of I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University)

MD, professor, Institute of Urology and Male Reproductive Health named

S. V Pesegov

FGAOU VO of I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University)

Cand.Med.Sci., urologist at the Department of Extracorporeal Shock-wave lithotripsy of UKB №2

Yu. G Alyaev

FGAOU VO of I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University)

corresponding member ofRAS, Dr.Med.Sci., professor

References

  1. Tiselius H.G. Medical evaluation of nephrolithiasis. Endocrinol Metab. Clin. North Am. 2002;31:1031-1050.
  2. Fisang С., Anding R., Lats S., Laude N. Dtsch Arztebl Int. 2015;112: 83-91.
  3. Gambaro G., Reis-Santos, J.M., Rao N. Nephrolithiasis: why doesn’t our ‘learning’ progress? Eur. Urol. 2004;45:547-556.
  4. Meneses J.A., Lucas F.M., Castro J.P., Monteiro R.B. The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res. 2012;40(3):225-229.
  5. Chandhoke P.S. When is medical prophylaxis cost-effective for recurrent calcium stones? J. Urol. 2002;168:937-940. doi: 10.1097/01. ju.0000024921.93877.f1
  6. Ferucci P.G., Sankey N., Chandhoke P.S. Am Surg. 2002;68(2):201-203.
  7. Siener R., Glatz S., Nicolay C., Hesse A. Prospectiv study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur. Urol. 2009;S8:205.
  8. Strohmaier W.L. 2012 Economics of stone disease/treatment. Arab J. Urol. 2012;10:273-278.
  9. Eisner B.H., Sheth S., Dretler S.P., Herrick B., Pais V.M. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers. Urology. 2012;80:776-779.
  10. Primiano A. et al. FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test. Dis. Markers. 2014;17:61-65.
  11. Kristensen C., Parks J.H., Lindheimer M., Coe F.L. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987;32:749-753.
  12. Evan A.P. et al. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat. Rec. (Hoboken) 2014;297,:731-748.
  13. Levine J.A., Neitlich J., Verga M., Dalrymple N., Smith R.C. Ureteral calculi in patient with flank pain: correlation of plain radiography with unenhanced helical CT. Radiology. 1997;204(1):27-31.
  14. Demirel A., Suma S. The efficacy of non-contrast helical cjmputed tomography in the prediction of urinary stone composition in vivo. J Int Med Res. 2003;31(1):1-5.
  15. Ascenti G. et al. Stone-targeted dual-energy CT: a new diagnostic approach to urinary calculosis. AJR Am. J. Roentgenol. 2010;195:953-958.
  16. Brown C.M., Ackermann D.K., Purich D.L. EQUIL93: a tool for experimental and clinical urolithiasis. Urol. Res. 1994;22:119-126.
  17. Robertson W.G. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall’s plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis. 2015;43(Suppl. 1):93-107
  18. Asplin J.R., Mandel N.S., Coe F.L. Evidence of calcium phosphate supersaturation in the loop of Henle. Am. J. Physiol. 1996;270:F604- F613.
  19. Kok D.J., Khan S.R. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney International. 1994;46(3):847-854.
  20. Robertson W.G. Kidney models of calcium oxalate stone formation. Nephron-Physiology. 2004;98(2)^21-p30.
  21. Finlayson B., Reid F. The expectation of free and fixed particles in urinary stone disease. Investigative Urology, 1978;15(6):442-448.
  22. Lotan Y., Jimenez I.B., Lenoir-Wijnkoop I., et al. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int. 2012.
  23. Безруков Е.А., Саенко В.С., Кантемиров Ф.Х., Кантемиров Д.Ф., Аляев Ю.Г. Влияние жесткости питьевой воды на возникновение мочекаменной болезни и химический состав камней у жителей городов Кумертау и Мелеуз. Медицинский вестник Башкортостана. 2015;3:83-87
  24. Константинова О.В., Яненко Э.К., Чудновская М.В., Кульга Л.Г. Влияние антибактериальных препаратов на рН мочи больных с кальций-оксалатной формой уролитиаза. Тезисы докл. «Экологические аспекты урологической патологии». Материалы IV конференции урологов Казахстана. Алма-Ата, 1992. C. 24-25
  25. Голованов С.А., Сивков А.В., Поликарпова А.М., Дрожжева В.В., Андрюхин М.И., Просянников М.Ю. Экспериментальная и клиническая урология. 2018;1:84-91
  26. Asplin J.R. Uric acid stones. Semin Nephrol. 1996;16:412-24.
  27. Taylor E.N., Stampfer M.J., Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-462.
  28. Powell C.R., Stoller M.L., Schwartz B.F., Kane C., Gentle D.L., Bruce J.E., et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825-830.
  29. Del Valle E.E., Negri A.L., Spivacow F.R., Rosende G., Forrester M., Pinduli I. Metabolic diagnosis in Stone formers in relation to body mass index. Urol Res. 2012;40:47-52.
  30. Taylor E.N., Curhan G.C. Body size and 24-hour urine composition. Am J. Kidney Dis. 2006;48:905-915.
  31. Daudon M., Lacour B., Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res. 2006;34:193-199.
  32. Daudon M., Lacour B., Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res 2006;34:193-199.
  33. Maalouf N.M., Sakhaee K., Parks J.H., Coe F.L., Adams-Huet B., Pak C.Y.C. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422-1425.
  34. Asplin J.R., Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565-669
  35. Robertson W.G., Heyburn P.J., Peacock M., Hanes F.A., Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond). 1979;57:285-288.
  36. Nelson W.K., Houghton S.G., Milliner D.S., Lieske J.C., Sarr M.G. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481-485.
  37. Дзеранов Н.К., Константинова О.В., Черепанова Е.В., Никонова Л.М., Лавринова Л.Н., Черный А.И., Иванов С.С. Применение минерально воды «Забручанская нафтуся» в комплексном лечении пациентов с мочекаменной болезню и хроническим пиелонефритом. Тезисы докладов II Всероссийская научно-практическая конференция с международным участием «Рациональная фармакотерапия в урологии, 2008». М., 2008. C. 7-8
  38. Константинова О.В., Катибов М.И., Яненко Э.К., Калиниченко Д.Н., Гецаев Т.К. Показатели ферментурии при рименении вода «Нафтуся» Забручанского месторождения в комплексном лечении больных с мочевыми камнями. Тезисы докл. Сб. материалов ХХ Юбилейного Российского национального конгресса «Человек и лекарство». М., 15-19 апреля 2013. C. 359
  39. Константинова О.В., Дутов В.В., Катибов М.И., Трапезникова М.Ф., Яненко Э.К., Меринов Д.С. Опыт применения минеральной воды «Нафтуся» Забручансекого местолрождения в лечении пациентов с мочевыми камнями. Урология. 2013;6:9-13
  40. Аляев Ю.Г., Амосов А.В., Саенко В.С., Шестиперов П.А., Мельников Д.В. Вода «Фьюджи» в метафилактике мочекаменной болезни. Врачебное сословие. 2008;2:36-40
  41. Ардашникова С.Н. Ардашников, М.С. Беленький, Л.С. Вишневский и д-р. Общая курортотерапия. Медгиз, 1959
  42. Antonelli I.B. Jimйnez H., Gharbi R.,. Herring A., Beaver A., Dennis D. Von Merveldt, Carter S., Cohen A., Poindexter J., Moe O.W., Pearle M.S. The kidney stone and increased water intake triaI in steeI workers: resuIts from a pilot study. Y. Lotan. J. Urolithiasis. doi: 10.1007/s00240-016-0892-7.
  43. Touhami M., Laroubi A., Elhabazi K., Loubna F., Zrara I., Eljahiri Y., Oussama A., Grases F.x, Chait A. Lemon juice has protective activity in a rat urolithiasis model. BMC Urology. 2007:18 https://doi.org/10.1186/1471-2490-7-18
  44. Birowo P., Widyahening I.S. Effect of citrus-based products on urine profile: A systematic review and meta-analysis. Nur Rasyid. 2017;6:220. doi: 10.12688/f1000research.10976.1.
  45. Siddiquia W.A., Shahzada M., Shabbirb A., Ahmadc A. Evaluation of anti-urolithiatic and diuretic activities of watermelon (Citrullus lanatus) using in vivo and in vitro experiments. Biomedicine & Pharmacotherapy. 2018;97:1212-1221.
  46. Grases F., Costa-Bauza A., Prieto R.M. May renal lithiasis be really prevented? New trends and therapeutic tools. Arch Esp Urol. 2017;70(1)91-102.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies